The Latest Breaking News from TGA

The healthcare complaints watchdog says at least two unnamed Sydney practitioners, allegedly posing as accredited medical professionals, are under investigation

TGA approved new indication for semaglutide drug in December 2024, but allocation to PBS still to be decided

The federal government yesterday released its response to the Senate inquiry into issues related to menopause. The inquiry recommended the government examine options to make menopause hormone therapy (MHT, or sometimes called hormone replacement therapy) more affordable and accessible, and address drug shortages.

Changes are coming into effect from February 1 about how paracetamol is sold in Australia.

Australia recently became the first country to legalize both MDMA and psilocybin-assisted psychiatric therapy

Australia’s Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included with the asthma and hay fever drug montelukast.

TikTok and Instagram influencers have been peddling the “Barbie drug” to help you tan.

A multi-million dollar business has developed in Australia to meet the demand for medicinal cannabis. Australians spent more than A$400 million on it in the first half of 2024 alone.

A growing number of consumers are presenting with symptoms linked to high levels of vitamin B6, pathologists say, while the supplement industry goes unpoliced

Australia’s sun care guidelines differ depending on your skin tone – but most people are not adequately protecting themselves

Exclusive: Critics say exemption ‘deeply concerning’ and risks creating separate assessment systems